Indrabahadur Singh
Co-founder @Plexobio
Signup · Get unlimited contacts
WORK HISTORY
Co-founder @Plexobio
Mannheim, DE
Help to develop and commercialize preclinical models and biospecimen services2. Serve biotech clients seeking translational readiness in oncology drug development3. Help to build infrastructure for tissue access, model validation, and early-stage partnerships
EDUCATION
Indian Institute of Technology, Roorkee
Master's degree, Biotechnology
Justus Liebig University Giessen
Dr. Rer. Nat., Biochemistry, Genetics, Pulmonary Pharmacotherapy and Molecular Genetics
Pfeiffer University
Advanced Business Development
Ramniranjan Jhunjhunwala College (Autonomous)
Bachelor's degree, Biotechnology
Technische Hochschule Mittelhessen
MBA, Business Administration and Management, General
Università degli Studi di Bergamo
International Business
SKILLS
ABOUT INDRABAHADUR SINGH
I’m a cancer biologist and translational researcher specializing in epigenetic mechanisms in cancer immunology and fibrosis. As Group Leader of the Ex-Emmy Noether Research Group “Epigenetic Machineries and Cancer” at the German Cancer Research Center (DKFZ), I led research on how chromatin regulators drive disease progression — and how we can target them.But throughout my academic journey, from a small village in India to one of Europe’s top research institutes, I’ve seen the same challenge play out:Scientific breakthroughs struggle to translate.Innovative targets, promising data, and early discoveries often get lost between academia and biotech — not due to lack of potential, but due to lack of structure, guidance, or access to the right tools.To address this, I founded: PlexoA GmbHA boutique service firm providing:1. Scientific & R&D due diligence2. Market & competitive landscape analysis3. Strategic Business & Development (BD) support for biotech, investors, and translational teams🧬 PlexoBio (early stage)A platform aim to offer AI and Blockchain powered:1. Custom preclinical models (oncology/fibrosis) access with pre-clinical and molecular data2. Human biospecimen access with clinical and molecular data3. Support for drug discovery, drug delivery, target validation and biomarker discoveryMy mission is simple:To bridge the gap between deep science and real-world impact. We make the inaccessible accessible. Open to:• SAB & advisory roles• R&D and BD collaborations• Sponsored research and partnershipsLet’s connect if you’re building something bold in epigenetics, oncology, tumor-immunology, fibrosis or translational science.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.